Servier agrees to acquire Day One Biopharmaceuticals for $2.5 billion, thereby entering the rare cancer fieldWallstreetcnMar 6, 2026 at 02:47 PMServier agrees to acquire Day One Biopharmaceuticals for $2.5 billion, entering the rare cancer field
